Skip to main content

Table 2 PTK6 protein expression and clinicopathologic features

From: Prognostic impact of PTK6 expression in triple negative breast cancer

Clinicopathologic features

LNM + 

P

LNM-

P

-

 + 

-

 + 

Histological type

  

0.451b

  

0.498a

 IDC

20

65

 

54

19

 

 Other types

2

15

 

23

11

 

Age(y)

  

0.368a

  

0.155a

  ≥ 50

10

45

 

40

11

 

  < 50

12

35

 

37

19

 

Site

  

0.656a

  

0.427a

 Left breast

13

43

 

50

17

 

 Right breast

9

37

 

27

13

 

Histological grading

  

0.308c

  

0.312c

 I

1

0

 

0

0

 

 II

6

25

 

30

20

 

 III

15

55

 

40

17

 

T stage

  

0.416b

  

0.181b

 T1-T2

21

69

 

74

26

 

 T3-T4

1

11

 

3

4

 

N stage

  

0.322b

  

N

 N1

16

49

 

N

N

 

 N2

4

12

 

N

N

 

 N3

2

19

 

N

N

 

HER2

  

0.917a

  

0.711a

 N

11

39

 

38

16

 

 L

11

41

 

39

14

 

D or R

  

0.078b

  

1b

 Yes

3

29

 

8

3

 

 No

19

51

 

69

27

 

Survival time(y)

  

0.018c

  

Nc

  < 5

0

15

 

0

0

 

  ≥ 5

22

55

 

79

30

 
  1. Represented PTK6 negative(IRS: 0–4); + represented, PTK6 Positive(IRS: 5–12), IDC Represented invasive ductal Carcinoma; Other types represented specific types of invasive ductal carcinoma; HER N represented HER2 negative; HER L represented HER2 low expression of HER2; D or R distant represented metastasis or recurrence. N represented not detected. P represented P value
  2. aPearson Chi-Square
  3. bContinuity Correction
  4. cFisher's Exact Test